NO993876L - 3'-N-oksid, 3'-N-dimetylamin, 9-oksim erytromycin A derivater - Google Patents

3'-N-oksid, 3'-N-dimetylamin, 9-oksim erytromycin A derivater

Info

Publication number
NO993876L
NO993876L NO993876A NO993876A NO993876L NO 993876 L NO993876 L NO 993876L NO 993876 A NO993876 A NO 993876A NO 993876 A NO993876 A NO 993876A NO 993876 L NO993876 L NO 993876L
Authority
NO
Norway
Prior art keywords
oxide
derivatives
dimethylamine
oxime
oxime erythromycin
Prior art date
Application number
NO993876A
Other languages
English (en)
Norwegian (no)
Other versions
NO993876D0 (no
Inventor
Yi-Yin Ku
David A Riley
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO993876L publication Critical patent/NO993876L/no
Publication of NO993876D0 publication Critical patent/NO993876D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO993876A 1997-02-13 1999-08-11 3'-N-oksid, 3'-N-dimetylamin, 9-oksim erytromycin A derivater NO993876D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/800,009 US5864023A (en) 1997-02-13 1997-02-13 3'-N'oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
PCT/US1998/001929 WO1998035976A1 (en) 1997-02-13 1998-02-03 3'-n-oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives

Publications (2)

Publication Number Publication Date
NO993876L true NO993876L (no) 1999-08-11
NO993876D0 NO993876D0 (no) 1999-08-11

Family

ID=25177295

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993876A NO993876D0 (no) 1997-02-13 1999-08-11 3'-N-oksid, 3'-N-dimetylamin, 9-oksim erytromycin A derivater

Country Status (25)

Country Link
US (1) US5864023A (pt)
EP (1) EP0966477B1 (pt)
JP (1) JP2001512456A (pt)
KR (1) KR100561326B1 (pt)
CN (1) CN1326865C (pt)
AR (1) AR012032A1 (pt)
AT (1) ATE252108T1 (pt)
AU (1) AU725274B2 (pt)
BG (1) BG64099B1 (pt)
BR (1) BR9807349A (pt)
CA (1) CA2279932C (pt)
CZ (1) CZ294481B6 (pt)
DE (1) DE69818977T2 (pt)
DK (1) DK0966477T3 (pt)
ES (1) ES2212266T3 (pt)
HU (1) HUP0001330A3 (pt)
IL (1) IL130697A0 (pt)
NO (1) NO993876D0 (pt)
NZ (1) NZ336482A (pt)
PL (1) PL187357B1 (pt)
PT (1) PT966477E (pt)
SK (1) SK284157B6 (pt)
TR (1) TR199901874T2 (pt)
WO (1) WO1998035976A1 (pt)
ZA (1) ZA98986B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100317907B1 (ko) * 1998-11-24 2001-12-24 김 완 주 신규한 중간체, 이를 이용한 마크로라이드계 항생제의제조방법
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
KR20010008496A (ko) * 1999-07-01 2001-02-05 유충식 6-오-메틸 에리트로마이신의 제조방법
KR100336447B1 (ko) * 1999-11-24 2002-05-15 민경윤 클라리스로마이신의 개선된 제조방법
WO2001044262A1 (en) * 1999-12-16 2001-06-21 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin polymorphs and novel polymorph iv
CA2397092A1 (en) * 2000-01-11 2001-07-19 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin polymorphs
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
WO2001064224A1 (en) 2000-02-29 2001-09-07 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
ATE338053T1 (de) * 2000-03-15 2006-09-15 Hanmi Pharm Ind Co Ltd Verfahren zur herstellung von clarythromycin mit nicht pharmazeutischer qualität
KR20000037126A (ko) * 2000-04-08 2000-07-05 김용규 6-메틸 에리스로마이신 ａ의 제조방법
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
CA2533292C (en) * 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1648418A4 (en) * 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
AU2004258949B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2535177A1 (en) * 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
EP1653924A4 (en) 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In ANTIBIOTICS, USE AND FORMULATION ASSOCIATED
CA2535780A1 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
US8460710B2 (en) * 2003-09-15 2013-06-11 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2007517039A (ja) * 2003-12-24 2007-06-28 アドバンシス ファーマスーティカル コーポレイション 変性放出製剤の吸収増強
CA2572292A1 (en) * 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
US7694523B2 (en) * 2004-07-19 2010-04-13 Earthrenew, Inc. Control system for gas turbine in material treatment unit
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US20090054634A1 (en) * 2007-08-09 2009-02-26 Vinod Kumar Kansal Process for the preparation of clarithromycin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
JPS61229895A (ja) * 1985-04-03 1986-10-14 Nippon Zeon Co Ltd 保護化デス−ｎ−メチルエリスロマイシン誘導体
EP0254534A3 (en) * 1986-07-24 1991-04-17 William S. Robinson Erythromycin derivatives and compositions and use for inhibiting virus replication and disease
DE3782994T2 (de) * 1986-09-18 1993-04-08 Taisho Pharma Co Ltd Erythromycin-a-derivate und verfahren zu ihrer herstellung.
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法

Also Published As

Publication number Publication date
PT966477E (pt) 2004-03-31
HUP0001330A2 (hu) 2000-08-28
BG64099B1 (bg) 2003-12-31
KR100561326B1 (ko) 2006-03-16
BR9807349A (pt) 2000-04-25
CZ270499A3 (cs) 1999-11-17
SK97499A3 (en) 2000-01-18
BG103673A (en) 2000-02-29
AU725274B2 (en) 2000-10-12
SK284157B6 (sk) 2004-10-05
CN1326865C (zh) 2007-07-18
IL130697A0 (en) 2000-06-01
DE69818977T2 (de) 2004-08-12
CZ294481B6 (cs) 2005-01-12
HUP0001330A3 (en) 2000-09-28
EP0966477A1 (en) 1999-12-29
ZA98986B (en) 1998-08-05
TR199901874T2 (xx) 2000-04-21
CN1246864A (zh) 2000-03-08
JP2001512456A (ja) 2001-08-21
NO993876D0 (no) 1999-08-11
KR20000070985A (ko) 2000-11-25
DE69818977D1 (en) 2003-11-20
NZ336482A (en) 2001-02-23
ATE252108T1 (de) 2003-11-15
CA2279932C (en) 2008-04-22
CA2279932A1 (en) 1998-08-20
EP0966477B1 (en) 2003-10-15
ES2212266T3 (es) 2004-07-16
PL187357B1 (pl) 2004-06-30
US5864023A (en) 1999-01-26
AR012032A1 (es) 2000-09-27
AU6260898A (en) 1998-09-08
PL335301A1 (en) 2000-04-10
WO1998035976A1 (en) 1998-08-20
DK0966477T3 (da) 2004-02-23

Similar Documents

Publication Publication Date Title
NO993876L (no) 3'-N-oksid, 3'-N-dimetylamin, 9-oksim erytromycin A derivater
ES2188896T3 (es) Derivados de 3'-dimetilamina, 9-eteroxima eritromicina a, protegida en 2'.
US6096714A (en) Erythromycin derivatives, method for preparing same, and use thereof as drugs
MX9703548A (es) Proceso para purificar y aislar 2'-desoxi-2',2'-difluoronucleosidos.
TR199901578T2 (xx) Klaritromisin form 0 kristali
AP9801253A0 (en) 9-Oxime erythromycin derivatives.
US4526889A (en) Epimeric azahomoerythromycin A derivative, intermediates and method of use
AU755315B2 (en) Novel 3,6-hemiketals from the class of 9a-azalides
IE821260L (en) Anthracycline derivatives
GEP20032899B (en) 5-O-Deosaminyl 6-O-Methyl Erythronolide A Derivatives and Method for Their Preparation
CZ20011803A3 (cs) Způsob přípravy makrolidových antibiotických látek z nových intermediátů
EP0124216A1 (en) C-20- and C-23-modified macrolide derivatives
EP1122252A4 (en) CONDENSED HEREROCYCLIC NITROGEN COMPOUNDS; MANUFACTURING PROCESS AND AGENTS CONTAINING THEM
CA2197467A1 (en) Method for the preparation of taxol and its derivatives
MY133397A (en) Novel crystalline forms of a macrolide antibiotic
Besson et al. Genetically controlled 2 ″-O-glycosylation of isovitexin in the petals of Melandrium album
AU7304394A (en) TTTr as protective group in nucleotide synthesis
EA003928B1 (ru) НОВЫЕ 15-ЧЛЕННЫЕ 8а- И 9а- ЛАКТАМЫ
EP1328535A1 (en) Macrolides
CA2376748A1 (en) Diphosphate salt of a 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition
HK1043597A1 (en) Novel derivatives from the class of oleandomycin
CA2250736A1 (en) 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin a derivatives
CA1202620A (en) Intermediates for the preparation of n-methyl 11-aza- 10-deoxo-10-dihydroerythromycin a
CA1250284A (en) Antibacterial epimeric azahomoerythromycin a derivative and production thereof
Hartenstein et al. Diastereoselective syntheses of 2-β-d-glucopyranosyloxy-2H-1, 4-benzoxazin-3 (4H)-ones from gramineae

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application